ARYA Sciences Acquisition Corp IV, trading under the ticker ARYD on Nasdaq, is a blank-check company sponsored by Perceptive Advisors, a New York-based life sciences-focused investment firm that has launched multiple SPAC vehicles under the ARYA Sciences franchise. The company completed its initial public offering in 2021 and targeted acquisition candidates in the life sciences, healthcare, and biotechnology sectors. The amended quarterly report on Form 10-Q/A filed in December 2021 reflects the company's status during its post-IPO search period for a qualifying business combination target. Perceptive Advisors' ARYA Sciences franchise is among the more prolific life sciences SPAC sponsors of the recent vintage. For comprehensive filing history, sponsor data, and real-time deal analytics on ARYD and hundreds of other vehicles, sign up for full access at SpacDesk.